GeneDx (WGS)

GeneDx (WGS) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• WGS last traded at $65.60, -5.01% on the day.
• GeneDx: market cap $2.06B, P/E -18.5, revenue $454.43M over the last four quarters, next earnings 2026-11-09.
• Over the past year WGS returned -50.11%; year to date -49.56%.

Updated 2026-11-02 17:58 UTC